跳至主要内容
临床试验/CTRI/2020/11/028918
CTRI/2020/11/028918已完成3 期

A randomised pilot control study to determine the safety,feasibility and effectiveness of octenidine on skin bacterial burden of neonates admitted in the neonatal intensive care unit

Bharati Hospital and research centre0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Neonates admitted in level 3 NICU, Bharati hospital and research centre (inborn as well as outborn),
  • a) Babies born at more than 28 weeksââ?¬• gestation and postnatal age of at least 24 hours OR
  • b) Babies admitted to NICU who are more than 4 weeks old

排除标准

  • Neonates with
  • a) congenital skin anomalies
  • b) extremely sick newborns, not allowing routine bathing care.
  • Extremely sick being defined as those newborns not mandating any kind of external movement for eg. those on high frequency oscillatory ventilation or those with pulmonary hypertension and requiring multiple inotropes
  • c) born less than 28 weeksââ?¬• gestation and less than 4 weeks of chronological age

研究者

发起方
Bharati Hospital and research centre

相似试验